Jon Jones CSAC Hearing Set For Feb 27

Nearly 7 months to the day after he was found to have failed a drug test and forced to relinquish the UFC light heavyweight title, Jon Jones will have a chance to defend himself in-front of the Calfornia State Athletic Commission (CSAC).

As reported by MMA Fighting, Jones will appear before the commission on February 27th in Anaheim, the site of his UFC 214 victory over Daniel Cormier in July, 2017. Jones won the fight, amidst a comeback from a prior drug related suspension, and regained the UFC light heavyweight title. Days following his win and media tour touting his successful return to the Octagon, Jones was found to have failed an in-competition drug test with Turinabol found in his system.

Following the State Commission’s hearing, which will likely include a fine and/or a suspension, Jones will still have to have an arbitration hearing with USADA, who is UFC’s anti-doping partner.

As reported here on FIGHT SPORTS, Jones’ agent Malki Kawa believes his client has a 95 percent chance to fight in 2018, following Jones passing a polygraph test proving he did not knowingly take the banned substance.

This is a similar situation to when Jones tested for clomiphene and Letrozol in an out-of-competition test prior to UFC 200. That failure, which he blamed was due to a male performance enhancing drug, which yielded a one year suspension from USADA, and now opens Jones up to a four year suspension.\

Jones and his team have staunchly denied that he knowingly took the steroid. Kawa told Thomas on SiriusXM that he believes there is a 95-percent chance Jones will fight before the conclusion of 2018.

Jones, the longtime former UFC light heavyweight champion, passed a polygraph test last month in effort to prove he did not knowingly take the banned substance.

You might also like
By using our site you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Service. X


Breaking News And Highlights Around Boxing, MMA, Kickboxing, Martial Arts and more!

By signing up, you agree to comply with our Terms of Service and Privacy Policy.